Novel ligands for P2 receptor subtypes in innervated tissues

Progress in Brain Research

Volumn 120, Issue , 1999, Pages 107-117

  Lambrecht, G ^a   Damer, S ^a   Niebel, B ^a   Czeche, S ^a   Nickel, P ^a   Rettinger, J ^a   Schmalzing, G ^a   Mutschler, E ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

8 (BENZAMIDO)NAPTHALENE 1,3,5 TRISULFONIC ACID; 8,8' [CARBONYLBIS(IMINO 4,1 PHENYLENECARBONYLIMINO 4,1 PHENYLENECARBONYLIMINO)]BIS(1,3,5 NAPHTHALENETRISULFONIC ACID); ECTO 5' NUCLEOTIDASE; LIGAND; NF 023; NF 031; PURINE P2X RECEPTOR; PURINE P2Y RECEPTOR; PURINERGIC RECEPTOR BLOCKING AGENT; PYRIDOXAL PHOSPHATE 6 AZOPHENYL 2',4' DISULFONIC ACID; RECEPTOR SUBTYPE; SURAMIN; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; COLON TENIA; CONTROLLED STUDY; DRUG POTENCY; DRUG SELECTIVITY; DRUG SYNTHESIS; ENZYME INHIBITION; GUINEA PIG; ILEUM; NONHUMAN; OOCYTE; PRIORITY JOURNAL; RAT; VAS DEFERENS; XENOPUS LAEVIS;

EID: 0032851078     PISSN: 00796123     EISSN: None     Source Type: Book Series    
DOI: 10.1016/s0079-6123(08)63549-9     Document Type: Article

References (52)

1. M.P. Abbracchio G. Burnstock Purinoceptors: Are there families of P2X and P2Y purinoceptors? Pharmacol. Ther. 64 1994 445 475
2. O. Arunlakshana H.O. Schild Some quantitative uses of drug antagonists Br. J. Pharmacol. 14 1959 48 58
3. E.A. Barnard J. Simon T.E. Webb Nucleotide receptors in the nervous system: An abundant component using diverse transduction mechanisms Molec. Neurobiol. 15 1997 103 130
4. M.W. Beukers C.J.M. Kerkhof M.A. Van Rhee U. Ardanuy C. Gurgel H. Widjaja P. Nickel A.P. IJzerman W. Soudijn Suramin analogs, divalent cations and ATPγS as inhibitors of ecto-ATPase Naunyn-Schmiedeberg's Arch. Pharmacol. 351 1995 523 528
5. S.S. Bhagwat M. Williams P2 purine and pyrimidine receptors: Emerging superfamilies of G-protein-coupled and ligand-gated ion channel receptors Eur. J. Med. Chem. 32 1997 183 193
6. M.R. Boarder S.M.O. Hourani The regulation of vascular function by P2 receptors: Multiple sites and multiple receptors Trends Pharmacol Sci. 19 1998 99 107
7. J.L. Boyer T. Romero-Avila J.B. Schachter T.K. Harden Identification of competitive antagonists of the P2Y1 receptor Mol. Pharmacol. 50 1996 1323 1329
8. A.J. Brake D. Julius Signaling by extracellular nucleotides Annu. Rev. CellDev. Biol. 12 1996 519 541
9. G. Buell G. Collo F. Rassendren P2X receptors: An emerging channel family Eur. J. Neurosci. 8 1996 2221 2228
10. R. Bültmann K. Starke Reactive red 2: a P2Y-selective purinoceptor antagonist and an inhibitor of ecto-nucleotidase Naunyn-Schmiedeberg's Arch. Pharmacol. 352 1995 477 482
11. R. Bültmann H. Wittenburg B. Pause G. Kurz P. Nickel K. Starke P2–purinoceptor antagonists: III. blockade of P2–purinoceptor subtypes and ecto-nucleotidases by compounds related to suramin Naunyn-Schmiedeberg's Arch. Pharmacol. 354 1996 498 504
12. R. Bültmann F. Tuluc K. Starke On the suitability of adenosine 3′-phosphate 5′-phosphosulphate as a selective P2Y receptor antagonist in intact tissues Eur. J. Pharmacol. 351 1998 209 215
13. E. Bungardt A. Buschauer U. Moser W. Schunack G. Lambrecht E. Mutschler Histamine H1 receptors mediate vasodilation in guinea-pig ileum resistance vessels: characterization with computer-assisted videomicroscopy and new selective agonists Eur. J. Pharmacol. 221 1992 91 98
14. G. Burnstock The past, present and future of purine nucleotides as signalling molecuies Neuropharmacology 36 1997 1127 1139
15. G. Burnstock C. Kennedy Is there a basis for distinguishing two types of P2–purinoceptor? Gen. Pharmacol. 16 1985 433 440
16. G. Burnstock B.F. King Numbering of cloned P2 purinoceptors Drug Dev. Res. 38 1996 67 71
17. G. Burnstock B. Fischer C.H.V. Hoyle M. Maillard A.U. Ziganshin A.L. Brizzolara A. von Isakovics J.L. Boyer T.K. Harden K.A. Jacobson Structure activity relationships for derivatives of adenosine-5′-triphosphate as agonists at P2 purinoceptors: Heterogeneity within P2X and P2Y subtypes Drug Dev. Res. 31 1994 206 219
18. E. Camaioni J.L. Boyer A. Mohanram T.K. Harden K.A. Jacobson Deoxyadenosine bisphosphate derivatives as potent antagonists at P2Y1 receptors J. Med. Chem. 41 1998 183 190
19. Z.-P. Chen A. Levy S.L. Lightman Nucleotides as extracellular signalling molecules J. Neuroendocrinol. 7 1995 83 96
20. G. Collo R.A. North E. Kawashima E. Merlo-Pich S. Neidhart A. Surprenant G. Buell Cloning of P2X5 and P2X6 receptors and the distribution and properties of an extended family of ATP-gated ion channels J. Neurosci. 16 1996 2495 2507
21. S. Czeche Niebel B. E. Mutschler G. Lambrecht Neuronal P2X-like receptors mediate cholinergic contraction via postjunctional muscarinic M3-receptors in guinea-pig ileal longitudinal smooth muscle Naunyn-Schmiedeberg's Arch. Pharmacol. 357 Suppl. 1998 R23
22. S. Czeche B. Niebel E. Mutschler P. Nickel G. Lambrecht P2-receptor heterogeneity in the guinea-pig ileal longitudinal smooth muscle preparation Drug Dev. Res. 43 1998 52
23. S. Damer B. Niebel S. Czeche P. Nickel U. Ardanuy G. Schmalzing J. Rettinger E. Mutschler G. Lambrecht NF279: A novel potent and selective antagonist of P2X receptor-mediated responses Eur. J. Pharmacol. 350 1998 R5 R6
24. S. Damer B. Niebel P. Nickel U. Ardanuy E. Mutschler G. Lambrecht NF279 and NF031, new selective P2X-receptor antagonists Naunyn-Schmiedeberg's Arch. Pharmacol. 357 Suppl. 1998 R34
25. O. Dudek R. Bültmann K. Starke Two relaxation-mediating P2–purinoceptors in guinea-pig taenia caeci Naunyn-Schmiedeberg's Arch. Pharmacol. 351 1995 107 110
26. B.B. Fredholm M.P. Abbracchio G. Burnstock J.W. Daly T.K. Harden K.A. Jacobson P. Leff M. Williams VI. Nomenclature and classification of purinoceptors Pharmacol Rev. 46 1994 143 156
27. B.B. Fredholm M.P. Abbracchio G. Burnstock G.R. Dubyak T.K. Harden K.A. Jacobson U. Schwabe M. Williams Towards a revised nomenclature for P1 and P2 receptors Trends Pharmacol. Sci. 18 1997 79 82
28. G. Hansmann R. Bültmann F. Tuluc K. Starke Characterization by antagonists of P2-receptors mediating endothelium-dependent relaxation in the rat aorta Naunyn-Schmiedeberg's Arch. Pharmacol. 356 1997 641 652
29. P.P.A. Humphrey G. Buell I. Kennedy B.S. Khakh A.D. Michel A. Surprenant D.J. Trezise New insights on P2X purinoceptors Naunyn-Schmiedeberg's Arch. Pharmacol. 352 1995 585 596
30. C.E. Iselin J.-L. Martin P.J. Magistretti J.D. Ferrero Stimulation by nicotine of enteric inhibitory nerves and release of vasoactive intestinal peptide in the taenia of the guinea-pig caecum Eur. J. Pharmacol. 148 1988 179 186
31. K.A. Jacobson Y.-C. Kim S.S. Wildman A. Mohanram T.K. Harden J.L. Boyer B.F. King G. Burnstock A pyridoxine cyclic phosphate and its 6-azoaryl derivative selectively potentiate and antagonize activation of P2X1 receptors J. Med. Chem. 41 1998 2201 2206
32. I. Kennedy P.P.A. Humphrey Evidence for the presence of two types of P2 purinoceptor in the guinea-pig ileal longitudinal smooth muscle preparation Eur. J. Pharmacol. 261 1994 273 280
33. B.S. Khakh A. Surprenant P.P.A. Humphrey A study on P2X purinoceptors mediating the electrophysiological and contractile effects of purine nucleotides in rat vas deferens Br. J. Pharmacol. 115 1995 177 185
34. G. Lambrecht Design and pharmacology of selective P2–purinoceptor antagonists J. Auton. Pharmacol. 16 1996 341 344
35. P. Leff B.E. Wood S.E. O'Connor Suramin is a slowly-equilibrating but competitive antagonist at P2X-receptors in the rabbit isolated ear artery Br. J. Pharmacol. 101 1990 645 649
36. C. Lewis S. Neidhart C. Holy R.A. North G. Buell A. Surprenant Coexpression of P2X2 and P2X3 receptor subunits can account for ATP-gated currents in sensory neurons Nature 377 1995 432 435
37. S. Moro D. Guo E. Camaioni J.L. Boyer T.K. Harden K.A. Jacobson Human P2Y1 receptor: Molecular modeling and site-directed mutagenesis as tools to identify agonist and antagonist recognition sites J. Med. Chem. 41 1998 1456 1466
38. R.A. Nicholas E.R. Lazarowski W.C. Watt Q. Li J. Boyer T.K. Harden Pharmacological and second messenger signalling selectivities of cloned P2Y receptors J. Auton. Pharmacol. 16 1996 319 323
39. A. Nicke H.G. Bäumert J. Rettinger A. Eichele G. Lambrecht E. Mutschler G. Schmalzing P2X1 and P2X3 receptors form stable trimers: A novel structural motif of ligand-gated ion channels EMBO J. 17 1998 3016 3028
40. R.A. North E.A. Barnard Nucleotide receptors Current Opinion Neurobiol. 7 1997 346 357
41. O. Pfaff C. Hildebrandt M. Waelbroeck X. Hou U. Moser E. Mutschler G. Lambrecht The (S)-(+)-enantiomer of dimethindene: A novel M2–selective muscarinic receptor antagonist Eur. J. Pharmacol. 286 1995 229 240
42. D.J. Prentice S.M.O. Hourani Adenosine analogues relax guinea-pig taenia caeci via an adenosine A2B receptor and a xanthine-resistant site Eur. J. Pharmacol. 323 1997 103 106
43. F. Soto M. Garcia-Guzman W. Stühmer Cloned ligand-gated channels activated by extracellular ATP (P2X receptors) J. Membr. Biol. 160 1997 91 100
44. F. Soto G. Lambrecht P. Nickel W. Stühmer A.E. Busch Antagonistic properties of the suramin analogue NF023 at heterologously expressed P2X receptors Neuropharmacology 38 1999 141 149
45. F. Tuluc R. Bültmann M. Glänzel A.W. Frahm K. Starke P2-receptor antagonists: IV. blockade of P2-receptor subtypes and ecto-nucleotidases by compounds related to reactive blue 2 Naunyn-Schmiedeberg's Arch. Pharmacol. 357 1998 111 120
46. A.M. Van Rhee M.P.A. Van der Heijden M.W. Beukers A.P. IJzerman W. Soudijn P. Nickel Novel competitive antagonists for P2–purinoceptors Eur. J. Pharmacol. 268 1994 1 7
47. C. Virginio G. Robertson A. Surprenant R.A. North Trinitrophenyl-substituted nucleotides are potent antagonists selective for P2X1, P2X3, and heteromeric P2X2/3 receptors Mol. Pharmacol. 53 1998 969 973
48. T.D. Westfall C.A. McIntyre S. Obeid J. Bowes C. Kennedy P. Sneddon The interaction of diadenosine polyphosphates with P2X-receptors in the guinea-pig isolated vas deferens Br. J. Pharmacol. 121 1997 57 62
49. U. Windscheif O. Pfaff A.U. Ziganshin C.H.V. Hoyle H.G. Bäumert E. Mutschler G. Burnstock G. Lambrecht Inhibitory action of PPADS on relaxant responses to adenine nucleotides or electrical field stimulation in guinea-pig taenia coli and rat duodenum Br. J. Pharmacol. 115 1995 1509 1517
50. A.U. Ziganshin L.E. Ziganshina B.F. King J. Pintor G. Burnstock Effects of P2-purinoceptor antagonists on degradation of adenine nucleotides by ecto-nucleotidases in folliculated oocytes of xenopus laevis Biochem., Pharmacol. 51 1996 897 901
51. H. Zimmermann Signalling via ATP in the nervous system Trends Neurosci. 17 1994 420 426
52. R. Ziyal A.U. Ziganshin P. Nickel U. Ardanuy E. Mutschler G. Lambrecht G. Burnstock Vasoconstrictor responses via P2X-receptors are selectively antagonized by NF023 in rabbit isolated aorta and saphenous artery Br. J. Pharmacol. 120 1997 954 960